(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy
Clinical trial NCT00354341 · COMPLETED
Trial details
- NCT number
- NCT00354341
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2005-07-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.